Krystal Biotech Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
/ 
Frequently asked questions
To buy Krystal Biotech Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Krystal Biotech Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Krystal Biotech Inc. is KRYS:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Krystal Biotech Inc. has its primary listing on NASDAQ (Small cap). You can trade Krystal Biotech Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Krystal Biotech Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Krystal Biotech Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Krystal Biotech Inc..